黄芪桑叶玉竹颗粒食用安全性评价-食品安全质量检测学报-CSCIED科技核心评价数据库-手机版

黄芪桑叶玉竹颗粒食用安全性评价

Study on edible safety evaluation of HuangqiSangyeYuzhu granules

ES评分 0 浏览量：227 下载量：0

DOI	10.19812/j.cnki.jfsq11-5956/ts.20250208005
刊名	食品安全质量检测学报 Journal of Food Safety and Quality
年，卷(期)	2025, 16(12)
作者	张悦, 牛相涛, 任娟, 周时蒙, 鄂敬文, 陈博文, 刘汉霞, 李翔,
作者单位	中国质量检验检测科学研究院; 中国检验检疫科学研究院综合检测中心
摘要	目的评价黄芪桑叶玉竹颗粒的食用安全性。方法通过小鼠急性经口毒性试验、3项遗传毒性试验、28 d经口毒性试验综合评估黄芪桑叶玉竹颗粒的食用安全性。结果小鼠急性经口毒性试验结果显示受试动物未见异常, 且黄芪桑叶玉竹颗粒的最大耐受剂量大于30.0 g/kg·BW, 属实际无毒性物质。细菌回复突变试验、哺乳动物红细胞微核试验及精原细胞染色体畸变试验结果均为阴性, 表明黄芪桑叶玉竹颗粒无遗传毒性。28 d经口毒性试验期间大鼠生长状况良好, 未见中毒体征, 血常规、血生化及病理学等检查指标均未见与黄芪桑叶玉竹颗粒相关的不良影响, 未观察到有害作用剂量为10.0 g/kg·BW。结论黄芪桑叶玉竹颗粒在本研究剂量范围内具有食用安全性。
Abstract	Objective To evaluate the edible safety of HuangqiSangyeYuzhu granules. Methods The edible safety of HuangqiSangyeYuzhu granules was comprehensively evaluated by acute oral toxicity test, 3 genotoxicity tests, and 28 d oral toxicity test. Results The results of acute oral toxicity test showed no abnormality in the test animals, and the maximum tolerated dose of HuangqiSangyeYuzhu granules was greater than 30.0 g/kg·BW, which was practically non-toxic substance. The results of bacterial reverse mutation test, mammalian erythrocyte micronucleus test and spermatogonial chromosome aberration test were negative, indicating that the HuangqiSangyeYuzhu granules had no genotoxicity. During the 28 d oral toxicity test, the rats growed well, and no signs of toxicity were observed, and no adverse effects associated with HuangqiSangyeYuzhu Granules were seen in blood routine, blood biochemistry, and pathology indices, and the no observed adverse effect level was 10.0 g/kg·BW. Conclusion HuangqiSangyeYuzhu granules have edible safety within the dosage range of this experiment.
关键词	黄芪桑叶玉竹颗粒;保健食品;毒理安全评价
KeyWord	HuangqiSangyeYuzhu granules; health food; toxicological safety evaluation
基金项目
页码	280-286

参考文献
相关文献

[1]International Diabetes Federation. IDF diabetes atlas. 10th ed
[M]. Brussels: Belgium, 2021.
[2]LIU Y, YU R, WANG X, et al. Research progress of the effective active ingredients of Astragalus mongholicus in the treatment of diabetic peripheral neuropathy
[J]. Biomed Pharmacother, 2024, 173: 116350.
[3]杨春红, 潘琳, 唐茜, 等.辅助降血糖功能的药食同源原料的应用概况
[J]. 中药与临床, 2022, 13(1): 103–114. YANG CH, PAN L, TANG X, et al. Overview of the application of medicinal and food ingredients with auxiliary hypoglycemic function
[J]. Chinese Medicine and Clinic, 2022, 13(1): 103–114.
[4]姜辉, 顾胜龙, 张玉婷, 等. 黄芪化学成分和药理作用研究进展
[J]. 安徽中医药大学学报, 2020, 39(5): 93–96. JIANG H, GU SL, ZHANG YT, et al. Progress of research on chemical composition and pharmacological effects of Astragalus
[J]. Journal of Anhui University of Traditional Chinese Medicine, 2020, 39(5): 93–96.
[5]SHEN Z, CUI T, LIU Y, et al. Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the “gut-kidney axis”
[J]. Phytomedicine, 2023, 121: 155129.
[6]陈思羽, 唐思梦, 王颖, 等. 黄芪多糖对2型糖尿病模型大鼠餐后1h血糖的影响
[J]. 中药新药与临床药理, 2020, 31(4): 28–33 CHEN SY, TANG SM, WANG Y, et al. Effects of astragalus polysaccharide on postprandial 1h blood glucose in rats with type 2 diabetes model
[J]. New Chinese Medicine and Clinical Pharmacology, 2020, 31(4): 28–33
[7]LI CX, LIU Y, ZHANG YZ, et al. Astragalus polysaccharide: A review of its immunomodulatory effect
[J]. Archives of Pharmacal Research, 2022, 45(6): 367–389.
[8]王德萍, 鱼晓敏, 安馨, 等. 桑叶多组分协同降血糖作用
[J]. 现代预防医学, 2018, 45(16): 2924–2928. WANG DP, FISH XM, AN X, et al. Synergistic hypoglycemic effect of multi-components of mulberry leaves
[J]. Modern Preventive Medicine, 2018, 45(16): 2924–2928.
[9]彭宝莹, 唐娇, 王进博, 等. 桑叶安全性及保健功能评价研究进展
[J]. 中国现代中药, 2021, 23(2): 389–394. PENG BY, TANG J, WANG JB, et al. Progress of research on safety and health function evaluation of mulberry leaves
[J]. Chinese Modern Traditional Medicine, 2021, 23(2): 389–394.
[10]CUI W, LUO K, XIAO Q, et al. Effect of mulberry leaf or mulberry leaf extract on glycemic traits: A systematic review and meta-analysis
[J]. Food Function, 2023, 14(3): 1277–1289.
[11]韩丽敏, 甘德成. “葛根-桑叶”药对治疗糖尿病肾脏病作用机制探讨
[J].中医药临床杂志, 2024, 36(6): 1088–1094. HAN LM, GAN DC. Discussion on the mechanism of action of “Pueraria mirifica-mulberry leaf” in the treatment of diabetic nephropathy
[J]. Chinese Medicine Clinical Journal, 2024, 36(6): 1088–1094.
[12]WANG Z, DU H, PENG W, et al. Efficacy and mechanism of Pueraria lobata and Pueraria thomsonii polysaccharides in the treatment of type 2 diabetes
[J]. Nutrients, 2022, 14(19): 3926.
[13]姚媛, 盖永强, 陈铁军, 等. 野生葛根与栽培葛根对慢性酒精中毒小鼠的护肝作用比较
[J]. 食品科学, 2022, 43(23): 174–179. YAO Y, GAI YQ, CHEN TJ, et al. Comparison of hepatoprotective effects of wild Pueraria mirifica and cultivated Pueraria mirifica on mice with chronic alcoholism
[J]. Food Science, 2022, 43(23): 174–179.
[14]赵容, 许亮, 谢明, 等. 中药玉竹的本草考证
[J]. 中国试验方剂学杂志, 2017, 23(15): 227–234. ZHAO R, XU L, XIE M, et al. Materia medica examination of the Chinese medicine yuzhu
[J]. Chinese Journal of Experimental Formulas, 2017, 23(15): 227–234.
[15]刘月新, 刘倩倩, 廖颖妍, 等. 玉竹多糖结构特征及其降糖生物活性研究进展
[J]. 现代中药研究与实践, 2022, 36(1): 98–102. LIU YX, LIU QQ, LIAO YY, et al. Progress in the study of structural characterization of polysaccharides and their hypoglycemic bioactivities of yucca
[J]. Modern Chinese Medicine Research and Practice, 2022, 36(1): 98–102.
[16]王雨宵, 常相伟, 陈博文, 等. 蜂胶化学成分、药理作用及临床应用研究进展
[Z]. 2022. WANG YX, CHANG XW, CHEN BW, et al. Progress of research on chemical composition, pharmacological effects and clinical application of propolis
[Z]. 2022.
[17]ZULLKIFLEE N, TAHA H, USMAN A. Propolis: Its role and efficacy in human health and diseases
[J]. Molecules, 2022, 27(18): 6120.
[18]冯文燕, 张东城, 许小红, 等. 甘肃道产黄芪毒理学安全性评价
[J]. 毒理学杂志, 2023, 37(6): 535–538. FENG WY, ZHANG DC, XU XH, et al. Toxicological safety evaluation of Astragalus membranaceus from Gansu Province
[J]. Journal of Toxicology, 2023, 37(6): 535–538.
[19]胡志航, 赵建斌, 柴建新, 等. 黄芪的毒理学试验研究
[J]. 中国卫生检验杂志, 2018, 28(18): 2206–2210. HU ZH, ZHAO JB, CHAI JX, et al. Experimental study on the toxicology of Astragalus membranaceus
[J]. Chinese Journal of Health Inspection, 2018, 28(18): 2206–2210.
[20]LI YZ, ZHANG XP, LIANG CL, et al. Safety evaluation of mulberry leaf extract: Acute, subacute toxicity and genotoxicity studies
[J]. Regulatory Toxicology and Pharmacology: RTP, 2018, 95: 220–226.
[21]詹键, 詹国瑛, 孙建琴. 葛根的毒性及致突变性研究
[J]. 贵阳医学院学报, 2000, 25(2): 177–178. ZHAN J, ZHAN GY, SUN JQ. Toxicity and mutagenicity of Pueraria mirifica
[J]. Journal of Guiyang Medical College, 2000, 25(2): 177–178.
[22]CHIVAPAT S, CHAVALITTUMRONG P, RATTANAJARASROJ S, et al. Toxicity study of puerariamirifica airy shaw et suvatabandhu
[J]. British Medical Bulletin, 2000, 42: 202–223.
[23]赵晋燕, 胡宇驰, 曹春然, 等. 中药复方保健产品安全性评价体系的要素探讨
[J]. 中华中医药杂志, 2022, 37(9): 5013–5018. ZHAO JY, HU YC, CAO CR, et al. Discussion on the elements of safety evaluation system of Chinese medicine compound health products
[J]. Chinese Journal of Traditional Chinese Medicine, 2022, 37(9): 5013–5018.
[24]冯鑫, 周博宇, 张晶莹, 等. 红参、百合、知母类保健食品安全性评价研究进展
[J]. 中国卫生工程学, 2024(1): 137–139. FENG X, ZHOU BY, ZHANG JY, et al. Progress of safety evaluation of red ginseng, lily of the valley and motherwort health food
[J]. China Health Engineering, 2024(1): 137–139.
[25]刘震营, 王玲娜, 张永清. 中国市场柏子仁真菌污染调查研究
[J]. 中国中药杂志, 2021, 46(1): 72–79. LIU ZY, WANG LN, ZHANG YQ. Investigation and study on fungal contamination of Cyperus rotundus in Chinese market
[J]. Chinese Journal of Traditional Chinese Medicine, 2021, 46(1): 72–79.
[26]李丽敏, 曹帅, 季申. 中药中重金属及有害元素控制的思考与建议
[J].中国食品药品监管, 2022(3): 104–109. LI LM, CAO S, JI S. Thoughts and suggestions on the control of heavy metals and harmful elements in traditional Chinese medicine
[J]. China Food and Drug Administration, 2022(3): 104–109.
[27]LI X, WANG L, LI S, et al. Evaluation of genotoxicity and teratogenicity of phillyrin
[J]. Toxicon, 2024, 249: 108080.
[28]LIN YE, LIN MH, YEH TY, et al. Genotoxicity and 28-day repeated dose oral toxicity study of garlic essential oil in mice
[J]. Journal of Traditional and Complementary Medicine, 2022, 12(6): 536–544.
[29]WANG P, WAN D, PENG T, et al. Acute oral toxicity and genotoxicity test and evaluation of Cinnamomum camphora seed kernel oil
[J]. Foods, 2023, 12(2): 293.
[30]贺圣凌, 赵兴丽, 周罗娜, 等. 红曲发酵夏秋茶毒理学评价
[J]. 食品安全质量检测学报, 2023, 14(2): 241–247. HE SL, ZHAO XL, ZHOU LN, et al. Toxicological evaluation of red fermented summer and fall tea
[J]. Journal of Food Safety & Quality, 2023, 14(2): 241–247.
[31]KALAIVANI P, SIVA R, GAYATHRI V, et al. Mutagenicity and safety evaluation of Ashwagandha (Withania somnifera) root aqueous extract in different models
[J]. Toxicology Reports, 2023, 12: 41–47.

引用本文

张悦, 牛相涛, 任娟, 周时蒙, 鄂敬文, 陈博文, 刘汉霞*, 李翔*. 黄芪桑叶玉竹颗粒食用安全性评价 [J]. 食品安全质量检测学报. 2025; 16; (12). 280 - 286.

文献评论

相关学者

相关机构